Related Experiment Video
Updated: Jun 26, 2026

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
Off-Pump Coronary Artery Bypass Leads to a Regional Hypercoagulable State Not Detectable Using Systemic Markers
Zachary N Kon1, Michael H Kwon, Michael J Collins
1Division of Cardiac Surgery, Department of Surgery, University of Maryland Medical System, Baltimore MD.
Off-pump coronary artery bypass grafting (OPCAB) may increase regional hypercoagulability, indicated by elevated thrombin and coagulation activation markers. This pilot study suggests OPCAB might need enhanced antithrombotic strategies due to localized clotting risks.
Area of Science:
- Cardiovascular Surgery
- Hematology
- Biochemistry
Background:
- Off-pump coronary artery bypass grafting (OPCAB) is theorized to induce hypercoagulability, but evidence remains inconclusive.
- Previous studies have not definitively documented a hypercoagulable state following OPCAB.
Purpose of the Study:
- To investigate the hypothesis that OPCAB increases the risk of a regional hypercoagulable state.
- To compare coagulation activation markers between OPCAB and on-pump CABG.
Main Methods:
- Transcardiac gradients of F1.2, FXIIa, myoglobin, IL-6, and IL-8 were measured post-CABG (off-pump N=69; on-pump N=35).
- Platelet-derived microparticles, platelet function, myocardial pH, and SVG flow were assessed.
- Endothelial integrity and graft patency were evaluated.
Main Results:
- OPCAB demonstrated significantly higher transcardiac levels of F1.2, FXIIa, microparticles, IL-6, and IL-8 compared to on-pump CABG.
- Myoglobin release was greater after OPCAB, correlating with regional pH changes and F1.2 release.
- Systemic markers showed less change post-OPCAB, while SVG flow was reduced, but endothelial integrity and graft patency remained similar.
Conclusions:
- Transcardiac assays revealed enhanced regional coagulation after OPCAB compared to on-pump CABG.
- These findings suggest OPCAB may necessitate additional antithrombotic therapies to manage localized hypercoagulability.
- Further research is required to confirm these results and guide clinical practice.
More Related Videos
05:25Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Coronary Artery Disease III: Clinical Manifestations